GS0051: Pharmaceutical, medicinal and veterinary preparations and substances, namely, vaccines, antitoxic sera, pharmaceutical preparations for the treatment of cancer, pharmaceutical preparations and substances for the treatment of thrombosis, embolisms, inflammation, and autoimmune disease, pharmaceutical preparations for the treatment of envenomation by snakes, veterinary preparations for the treatment of envenomation by snakes, and dietetic foods adapted for medical use, namely, food supplements containing vitamins, minerals, trace elements, oils and fats, either apart or in combinations thereof for use in the treatment of cardiovascular issues, vascular issues or cancer, liquid medical sealants, and liquid adhesives for use in surgical and clinical procedure; pharmaceutical and medicinal preparations and substances, namely, vaccines and vaccine adjuvants, proteins, peptides, sera containing polyclonal antibodies and fragments thereof and polyclonal antibodies and fragments derived therefrom all for use in treating snake envenomation, overdose of toxic substances, and sepsis; drug delivery agents, namely, preparations and substances for facilitating the delivery of pharmaceutical and medicinal preparations and substances; preparations and substances for facilitating the delivery of pharmaceutical and medicinal preparations and substances, namely, drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; pharmaceutical preparations and substances for use in the circulatory system; pharmaceutical preparations and substances for embolisation; pharmaceutical preparations and substances for embolisation of tumours and arteriovenous malformations (AVMs); pharmaceutical preparations and substances for use in the circulatory system for the treatment of tumours and AVMs; adjuvants for medicinal purposes, vaccine adjuvants and vaccine preparations containing adjuvant; chemical reagents for medical and veterinary purposes for the treatment of envenomation by snakes; chemical reagents for therapeutic and diagnostic purposes for the treatment of envenomation by snakes; chemico-pharmaceutical preparations for the treatment of envenomation by snakes; chemical preparations for medical and pharmaceutical purposes for the treatment of envenomation by snakes; medicines for the treatment of envenomation by snakes; pharmaceutical and veterinary preparations for the treatment of digoxin, digitalis and other cardio-active glycoside toxicity; pharmaceutical and veterinary preparations for the treatment of pre-eclampsia; chemical reagents for medical and veterinary therapeutic and diagnostic purposes; chemico-pharmaceutical preparations for use in the treatment of digoxin, digitalis and other cardio-active glycoside toxicity, and for use in the treatment of pre-eclampsia; chemical preparations for medical and pharmaceutical purposes and medicines for use in the treatment of digoxin, digitalis and other cardio-active glycoside toxicity and for use in the treatment of pre-eclampsia; transarterial chemoembolisation pharmaceutical preparations, vaccines and sera; pharmaceutical preparations and substances for facilitating the delivery of pharmaceutical and medicinal preparations and substances, namely, therapeutic agents for delivery of radioactive materials to target sites within the body for the treatment of cancer; irradiated and radioactive microspheres used for in vivo therapeutic medical purposes, namely, beads in the nature of microscopic glass beads impregnated with radioactive pharmaceutical preparations for treatment of cancerous tumors; radiotherapy substances for medical purposes, namely, radioactive pharmaceutical preparations for medical purposes for the treatment of cancer; radiopharmaceuticals, namely, radiopharmaceuticals for the treatment of cancer and radiopharmaceutical preparations for use in nuclear medicine; therapeutic agents for delivery of radioactive material to target sites within the body; beads, including microscopic radioactive beads featuring pharmaceutical preparations for treatment of cancerous tumours; beads, including microscopic glass beads, impregnated with pharmaceutical preparations and consisting of radioactive material for treatment of cancerous tumours; radioactive glass beads; radioactive glass beads impregnated with pharmaceutical preparations used to treat cancerous tumors; pharmaceutical preparations for use with ultrasound waves to enhance drug delivery and medically activate drugs; pharmaceutical preparations in the form of foams for use in sclerotherapy treatment of veins; pharmaceutical preparations in the form of foams for use in producing foams for use in sclerotherapy treatment of veins; pharmaceutical preparations in the form of foams and for use in preparing foams, for sclerotherapy, phlebology, angiology and proctology, namely, for the treatment of oesophageal varices, hydroceles, in sterilisation treatment and for treatment of varicose veins, and arterio-venous malformations; pharmaceutical preparations containing methotrexate antidotes; pharmaceutical preparations containing 5-fluorouracil antidotes; pharmaceutical preparations for use in chemotherapy and for the treatment of autoimmune diseases; pharmaceutical preparations used for regulating toxicity levels of therapeutic agents; pharmaceutical preparations used for depleting concentrations of therapeutic agents
GS0101: Surgical, medical and veterinary apparatus and instruments, namely, medical syringes, surgical and medical apparatus for producing and administering pharmaceutical foams, surgical and medical apparatus for producing foams for treatment of varicose veins, arterio-venous malformations, oesophageal varices and hydroceles, devices for intravenous administration of pharmaceutical foam, and diagnostic devices for grading the severity of venous conditions, snake envenomation and toxic drugs overdose; surgical, medical and veterinary apparatus and instruments, namely, medical devices for use in pulmonary and thoracic surgery and procedures, lung air trapping reduction coils, lung volume reduction devices, surgical implants comprising artificial material, surgical implants comprising artificial materials for restoring, maintaining and improving patient breathing and artificial surgical implants for restoring, maintaining and improving lung function, and catheters for deploying these; surgical, medical and veterinary apparatus and instruments, namely, medical device, apparatus and instruments for treating cancer; drug delivery embolisation apparatus, instruments and systems; apparatus and instruments for use in the circulatory system, namely, catheters, injection syringes and sealed vials; medical apparatus and instruments for embolisation; surgical and medical apparatus and instruments, namely, catheters, injection syringes and sealed vial devices for dispensing microspheres during embolisation procedures in blood vessels and in the circulatory system; embolisation apparatus, instruments and systems comprising surgical and medical instruments for embolization, namely, embolic devices for use in treating cancer and tumors, embolic devices for treating arteriovenous malformations (AVMs) of the body, and embolic devices for use in treating tumors; drug delivery embolisation systems; drug delivery apparatus and instruments, namely, a drug delivery system comprised of injection syringes and sealed vials; injection syringes for use with catheters; apparatus and instruments for use in the circulatory system, namely, catheters, injection syringes and sealed vials for dispensing microspheres during embolisation procedures in blood vessels and in the circulatory system; medical apparatus and instruments for embolization, namely, medical devices in the nature of particles, namely, embolic microspheres for embolization; surgical and medical apparatus and instruments for embolisation, namely, embolisation apparatus, instruments and systems comprising microspheres and injection syringes for use in blood vessels and the circulatory system to carry out embolisation; radiotherapy apparatus; surgical and medical apparatus and instruments for delivery of radiopharmaceuticals and radioactive material to target sites within the body; beads, namely, microscopic radioactive glass beads impregnated with radioactive material or containing radioactive material and administered surgically for treatment of cancerous tumours; radioactive beads, namely, radioactive glass beads administered for treatment of cancerous tumours; surgical and medical apparatus and instruments for use in the circulatory system; medical devices in the nature of drug delivery systems which use ultrasound to enhance drug delivery and medically activate drugs; catheters for delivery of drugs and fluids sold together as a unit with controllers and power units for infusion catheters; ultrasonic drug delivery and drug activation apparatus sold together as a unit with controllers and power units therefor; needles for medical use, namely, cannula needles; medical tubing for sclerotherapy; medical tubing for the treatment of varicose veins, venous malformations, arterio-venous malformations, oesophageal varices and hydroceles; surgical and medical apparatus for producing and administering foams for the treatment of varicose veins, venous malformations, arterio-venous malformations, oesophageal varices and hydroceles; surgical and medical apparatus for producing and administering sclerosing foams for the treatment of varicose veins, venous malformations, arterio-venous malformations, oesophageal varices and hydroceles; surgical and medical apparatus for producing and administering foams for use in sclerotherapy, phlebology, angiology and proctology; syringes for producing and administering foams for use in sclerotherapy, phlebology, angiology and proctology; surgical and medical apparatus for administering and producing foams for use in sterilisation treatment; surgical and medical apparatus for use in treatment of varicose veins, arterio-venous malformations, oesophageal varices and hycroceles; syringes for use in treatment of varicose veins, arterio-venous malformations, oesophageal varices and hydroceles; devices for assessing the physical characteristics of such foams, namely, medical diagnostic apparatus for analyzing the efficacy of sclerotherapy foams for medical purposes; medical devices for intravenous administration of sclerosing foam for the treatment of varicose veins, venous malformations, arterio-venous malformations, oesophageal varices and hydroceles; medical devices for monitoring the position and effect of sclerosing foam in the human body for the treatment of varicose veins, venous malformations, arterio-venous malformations, oesophageal varices and hydroceles; medical diagnostic apparatus for diagnosing all the above medical conditions, namely, varicose veins, arterio-venous malformations, oesophageal varices, spider veins hydroceles, cancer, tumors, and circulatory system conditions and pulmonary and thoracic conditions; compression bandages; component parts and fittings for all of the aforesaid goods; irradiated or radioactive microspheres used for in vivo therapeutic medical purposes, namely, implantable radiation therapy devices consisting of radioactive beads, namely, beads in the nature of microscopic radioactive beads for treatment of cancerous tumours; implantable radiation therapy devices consisting of radioactive beads and a bioabsorbable carrier assembly, namely, beads in the nature of radioactive microscopic beads impregnated with radioactive material for treatment of cancerous tumours and beads in the nature of radioactive microscopic glass beads impregnated with radioactive material for treatment of cancerous tumours; radioactive glass beads, namely, implantable radiation therapy devices consisting of radioactive beads and a bioabsorbable carrier assembly and implantable radiation therapy devices consisting of radioactive beads; radioactive glass beads, namely, implantable radiation therapy devices consisting of radioactive glass beads administered for treatment of cancerous tumours; medical devices in the nature of radioactive glass beads administered for treatment of cancerous tumors
GS0411: Education, namely, developing, arranging and conducting educational conferences, seminars, workshops and programs and providing courses of instruction in the fields of healthcare, the use of pharmaceuticals and medical devices, medical research, surgery, medical science, medicine, medical diseases, disorders and related treatments; provision of educational content namely, providing on-line instruction in the fields of healthcare, the use of pharmaceuticals and medical devices, medical research, surgery, medical science, medicine, medical diseases, disorders and related treatments; providing computer, electronic and online databases featuring information about medical education in the field of healthcare, medicine, medical treatment and patient care; training in the use and operation of pharmaceutical products, pharmaceutical preparations, radiopharmaceutical preparations, medical devices, medical imaging apparatus and medical research apparatus and consultation relating thereto; educational services, namely, conducting live and online seminars, classes, workshops, conferences, lectures, panel discussions, and training programs in the fields of healthcare, the use of pharmaceutical and medical devices, medical research, surgery, medical science, medicine and medical diseases, disorders and related treatments; Educational services, namely, providing non-downloadable webinars in the fields of healthcare, the use of pharmaceuticals and medical devices, medical research, surgery, medical science, medicine, medical diseases, disorders and related treatments; educational services, namely, conducting live and online seminars, classes, workshops, conferences, lectures, panel discussions and training in the field of health; educational services, namely, providing non-downloadable webinars in the field of health; education services, namely, conducting online and telephonic instruction and courses in the fields of health and medical issues
GS0441: Medical services; surgical diagnostic services; provision of medical and surgical information; provision of medical and surgical information on-line from a computer database or from the Internet or by telecommunication means; healthcare services; services for the provision of medical information; providing medical information; medical services relating to ultrasound waves to enhance drug delivery and medically activate drugs; dissolution of thrombotic blood clot material using catheters; medical services in the nature of dissolution of thrombotic blood clot material using catheters; providing a website featuring information regarding medicine, medical treatment, patient care, prescription drugs, ordering, prescribing, and dispensing practices of drugs, treatment and aftercare; providing a website featuring medical information regarding medicine, medical treatment, patient care, prescription drugs, ordering, prescribing, and dispensing practices of drugs, treatment and aftercare; medical and veterinary services, namely, diagnosis, assessment, treatment and aftercare in the fields of sclerotherapy, phlebology, angiology, proctology, interventional oncology, ablation of tumours using embolic beads, ablation of tumours using embolic radioactive beads, ablation of tumours using embolic drug eluting beads, and in connection with varicose veins, arterio-venous malformations, oesophageal varices, hydroceles and sterilisation treatment; medical analysis for the diagnosis and treatment of persons; pharmacy advice; pharmacy advice, namely, medical advice on pharmaceuticals; medical services for diagnosis in the fields of sclerotherapy, phlebology, angiology and proctology and in particular, in relation to varicose veins, arterio-venous malformations, oesophageal varices, hydroceles and sterilisation treatment; medical health assessment services in the fields of sclerotherapy, phlebology, angiology and proctology and in particular, in relation to varicose veins, arterio-venous malformations, oesophageal varices and sterilisation treatment; medical treatment services in the fields of sclerotherapy, phlebology, angiology and proctology and in particular, in relation to varicose veins, arterio-venous malformations, oesophageal varices and sterilisation treatment; medical after care services in the fields of sclerotherapy, phlebology, angiology and proctology and in particular, in relation to varicose veins, arterio-venous malformations, oesophageal varices and sterilisation treatment; advisory services relating to health and healthcare; advisory services relating to medicine and medical treatment and services; medical advisory services relating to patient care; conducting health assessment surveys, health risk assessment surveys, treatment outcome surveys and health advice and information services; health care consultancy services; consultancy services relating to medical treatment; information services relating to health care and medical treatment; providing health and medical information via hotline services enabling medical, counselling, and nursing personnel access to records to enable assistance with patient coverage, reimbursement, ordering, and site-of-care support questions; provision of medical records by hotline services; healthcare consultancy services, namely, providing a hotline for medical, counselling and nursing personnel; healthcare consultancy services, namely, providing patient and patient medical record information by hotline services; providing health and medical information by hotline services; advisory services relating to health and healthcare; advisory services relating to medicine and medical treatment and services; medical advisory services relating to patient care; healthcare consultancy services; consultancy services relating to medical treatment; information services relating to healthcare and medical treatment; medical equipment rental; advisory services relating to medical apparatus, instruments and preparations; medical advisory services relating to medical apparatus, instruments and preparations; advisory services relating to medical services; Medical services relating to treatment of snakebite envenomation, digoxin or digitalis toxicity, methotrexate toxicity, fluorouracil toxicity and chemotherapy toxicity; performance of surgical procedures; preparation of medical reports; providing medical information about liquid medical sealants and liquid adhesives for use in surgical and clinical procedures; medical, surgical, dental, veterinary and hygienic care; advisory, consultancy and information services relating to the aforesaid services
Case File Event Statements
6/19/2017 - 7 years ago
30 - ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDType:MAB6
6/19/2017 - 7 years ago
29 - ABANDONMENT - NO USE STATEMENT FILEDType:ABN6
9/16/2016 - 8 years ago
28 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILEDType:EXRA
9/14/2016 - 8 years ago
27 - EXTENSION 1 GRANTEDType:EX1G
9/14/2016 - 8 years ago
26 - EXTENSION 1 FILEDType:EXT1
9/14/2016 - 8 years ago
25 - TEAS EXTENSION RECEIVEDType:EEXT
5/17/2016 - 8 years ago
24 - NOA E-MAILED - SOU REQUIRED FROM APPLICANTType:NOAM
3/22/2016 - 8 years ago
23 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILEDType:NPUB
3/22/2016 - 8 years ago
22 - PUBLISHED FOR OPPOSITIONType:PUBO
3/2/2016 - 8 years ago
21 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILEDType:NONP
2/12/2016 - 8 years ago
20 - LAW OFFICE PUBLICATION REVIEW COMPLETEDType:PREV
2/5/2016 - 8 years ago
19 - APPROVED FOR PUB - PRINCIPAL REGISTERType:CNSA
2/5/2016 - 8 years ago
18 - EXAMINER'S AMENDMENT ENTEREDType:XAEC
2/5/2016 - 8 years ago
17 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILEDType:GNEN
2/5/2016 - 8 years ago
16 - EXAMINERS AMENDMENT E-MAILEDType:GNEA
2/5/2016 - 8 years ago
15 - EXAMINERS AMENDMENT -WRITTENType:CNEA
2/4/2016 - 8 years ago
14 - TEAS/EMAIL CORRESPONDENCE ENTEREDType:TEME
2/3/2016 - 8 years ago
13 - CORRESPONDENCE RECEIVED IN LAW OFFICEType:CRFA
2/3/2016 - 8 years ago
12 - TEAS RESPONSE TO OFFICE ACTION RECEIVEDType:TROA
8/4/2015 - 9 years ago
11 - NOTIFICATION OF NON-FINAL ACTION E-MAILEDType:GNRN
8/4/2015 - 9 years ago
10 - NON-FINAL ACTION E-MAILEDType:GNRT
8/4/2015 - 9 years ago
9 - NON-FINAL ACTION WRITTENType:CNRT
7/28/2015 - 9 years ago
8 - ASSIGNED TO EXAMINERType:DOCK
7/8/2015 - 9 years ago
7 - APPLICANT AMENDMENT PRIOR TO EXAMINATION - ENTEREDType:AMPX
7/7/2015 - 9 years ago
6 - ASSIGNED TO LIEType:ALIE
6/30/2015 - 9 years ago
5 - ASSIGNED TO LIEType:ALIE
6/19/2015 - 9 years ago
4 - ASSIGNED TO LIEType:ALIE
6/11/2015 - 9 years ago
3 - TEAS VOLUNTARY AMENDMENT RECEIVEDType:PARI
5/16/2015 - 9 years ago
2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAMType:NWOS
Trademark
86622922
